# Apheresis of Patients With Immunodeficiency

> **NCT01212055** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 7 (estimated)

## Conditions studied

- LAD-1
- DOCK8
- GATA2 Deficancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01212055
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2010-11-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212055, "Apheresis of Patients With Immunodeficiency". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01212055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*